Dr Elena Schneider-Futschik
Contact details are only visible to registered journalists. To register click hereNHMRC Research Fellow (Biochemistry & Pharmacology)
The University of Melbourne
Melbourne, VIC, Australia
Expertise
Cystic fibrosis, respiratory diseases, lung diseases, lung infections, antibiotics, pharmacology, CFTR modulators, ivacaftor, lumacaftor, tezacaftor, elexacaftor, air quality, asthma, COPD, drug treatment, drug interactions, toxicology, clinical pharmacology, adverse drug effectsMedia
More Media Info
Previous media experience
I have spoken at multiple conferences nationally and internationally. As the Young Ambassador to Australia for the American Society for Microbiology I host seminars and workshops.
Links to media clippings
Biography
Dr Elena Schneider-Futschik is a specialist in pharmacology and lung health. As a National Health and Medical Research Council Fellow she leads the cystic fibrosis pharmacology research program across the department “Biochemistry & Pharmacology ” at the University of Melbourne aiming to optimise currently available treatments.For her PhD she received the Mollie Holman Medal which is one of the highest honours Monash University bestows. She has received awards and research support from both public and philanthropic organisations including the Thoracic Society of Australia and New Zealand, Australian Society Clinical and Experimental Pharmacology and Toxicology, the University of Melbourne and the NHMRC.
She frequently presents to community groups and clinicians actively disseminating and translating her clinical research in lung health. Elena was the Australian Delegate to attend the Lindau Nobel Laureate Meeting (2018), a recipient of the John Bertrand Leadership Excellence Award (2017) or Infectious Disease Fellow Award (2016).
Personal info
Gender:
Female
Languages besides English:
German
Last updated: 28 Feb 2023